Kronos Bio (KRON) highlighted preclinical data from its p300 KAT inhibitor program for autoimmune indications at the American College of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback